Sab Biotherapeutics, Inc. · NASDAQ:SABS
Adage Capital Management, L.P. reported a 8.38% stake in Sab Biotherapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 12, 2026
Adage Capital Management, L.P. reported a 8.38% stake in Sab Biotherapeutics, Inc., 6,405,553 shares, as a passive investor on Jun 30, 2026. Filed Aug 12, 2026 (Schedule 13G).
- Stake
- 8.38%
- Shares
- 6,405,553
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 8.38% | 6,405,553 |
| Robert Atchinson | 8.38% | 6,405,553 |
| Phillip Gross | 8.38% | 6,405,553 |
Source
Related
- Sab Biotherapeutics, Inc.
- Adage Capital Management, L.P.
- Sab Biotherapeutics, Inc. shareholders
- Form 4 · Kropotova Alexandra · Sep 18, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G/A · Woodline Partners LP · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Caligan Partners LP · Aug 14, 2026